| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5104863 | Value in Health | 2017 | 9 Pages |
Abstract
Sacubitril/valsartan can be considered a cost-effective treatment at a daily price of â¬5.25. Unless priced lower than enalapril (<â¬0.045 per day), sacubitril/valsartan is very unlikely to be cost-saving/dominant.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Simon BSc, Fabian MSc, Maarten J. PhD, Pepijn PhD,